The A17 Bionic chip initially used in the iPhone 15 Pro and iPhone 15 Pro Max later this year will fundamentally differ from a version of the same chip set to be manufactured in 2024, a new rumor claims.
The A17 Bionic is expected to be Apple’s first chip manufactured with a 3nm fabrication process, resulting in major performance and efficiency improvements over the 5nm technique used for the A14, A15, and A16 chips. The initial version of the A17 Bionic chip will reportedly be manufactured using TSMC’s N3B process, but Apple is planning to switch the A17 over to N3E sometime next year. The move is said to be a cost-cutting measure that could come at the expense of reduced efficiency.
Comments are closed.